Portfolio

Investments

View all

YM Biosciences, Inc.
AMEX: YMI

Product development company focused on advancing cancer products along the regulatory and clinical pathways towards commercial approval

Sector: Biopharmaceuticals, Healthcare
Company Status: Public
Investment Status: Historical

Associated Team Members:
James Barrett, PhD

Back to Previous